Macromoltek GTM brain

Macromoltek provides computational antibody discovery and engineering services to biotech and pharmaceutical R&D teams.

category

Computational antibody design

market profile

  • text: Therapeutic antibody teams use computational modeling to narrow candidates and support experimental discovery.
  • text: Antibody design competes across in-house experimental platforms, modeling software and specialist AI partners.

personas

  • title: Head of antibody discovery
    pains:
    • Conventional screens struggle with difficult targets
    • Lead discovery consumes expensive experimental cycles
  • title: Computational biology or protein engineering lead
    pains:
    • Needs structural predictions and epitope insight
    • Must balance binding properties with developability
  • title: Biotech R&D executive
    pains:
    • Small internal teams lack specialized antibody design capacity
    • Needs to advance candidates with constrained runway

icp

  • text: Biotech companies developing antibody therapeutics from target identification through lead optimization.
  • text: Pharmaceutical research groups needing external computational antibody engineering for specific targets.

message pillars

  • text: Accelerate discovery with computational modeling and AI.
  • text: Improve structural insight and cut experimental iteration.
  • text: Offer a tailored scientific partnership for each target.

objections

  • objection: Will predicted binders work in the lab?
    response: Review target-specific validation, proposed assays and experimental milestones before committing to a program.
  • objection: How will our team retain control of the program and IP?
    response: Define collaboration scope, deliverables, data access and ownership in the partnership agreement.
  • objection: We already have an internal discovery platform.
    response: Assess a difficult target or structure modeling bottleneck where external design can complement existing workflows.

competitors

  • name: EVQLV
    why: Computational antibody discovery company listed alongside Macromoltek.
  • name: MAbSilico
    why: Competes in computational antibody discovery and analysis.
  • name: Schrödinger
    why: Its BioLuminate software supports computational antibody modeling.

influencers

  • name: Monica Berrondo
    url: https://www.linkedin.com/in/monicaberrondo
    why: Founder and antibody modeling scientist with publications on antibody structure and design.

keywords

  • computational antibody design
  • AI antibody discovery
  • antibody structure modeling
  • antibody lead optimization
  • antibody epitope mapping
  • difficult target antibody discovery

voice

  • technical
  • research-oriented
  • collaborative

signals

  • text: Biotech announces a new antibody target or lead optimization program.
  • text: A pharma team seeks external protein engineering for difficult targets.

pricing

model: unknown

motion

sales_led

channels

  • SEO
  • LinkedIn
  • scientific publications
  • events

confidence

medium

Founders

  • name: Monica Berrondo
    title: Founder/CEO
    role: CEO
    bio: Monica Berrondo, Ph.D., is an entrepreneur, scientist, and software engineer. Her expertise lies in antibody structure-prediction and analysis, protein functional analysis, protein mutational analysis, and computational approaches to complex scientific problems.
  • name: Susana Kaufmann
    title: Founder/CTO
    role: CTO

Back to YC companies